Get into GSK Pharma at 2050-2000 levels: Ashwani Gujral
"GSK in a range of 2050 to about 2450, it has been there for last odd 6 months. So chances are it will continue to stay there."
By 
| Updated:
| Updated: Ashwani Gujral, Chief Market Strategist, ashwanigujral.com in an interview with ET Now talks about GSK Pharma.
What is the call on GSK Pharma?
GSK Pharma is a low volume type stock, does not move a whole lot. So maybe Aurobindo Pharma will find resistance around 220. On the downside, you will probably get levels of 160. These days, pharmas are getting a lot of bad news. So maybe it is not such a good idea to treat them as defensives.
The only defensives are oil sensitives from here, BPCL, HPCL. So GSK in a range of 2050 to about 2450, it has been there for last odd 6 months. So chances are it will continue to stay there. If you have to get into this, maybe around 2050-2000 is a good place to get into.
What is the call on GSK Pharma?
GSK Pharma is a low volume type stock, does not move a whole lot. So maybe Aurobindo Pharma will find resistance around 220. On the downside, you will probably get levels of 160. These days, pharmas are getting a lot of bad news. So maybe it is not such a good idea to treat them as defensives.
The only defensives are oil sensitives from here, BPCL, HPCL. So GSK in a range of 2050 to about 2450, it has been there for last odd 6 months. So chances are it will continue to stay there. If you have to get into this, maybe around 2050-2000 is a good place to get into.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
When Ashwani Gujral predicted current stock market selloff just a few days agoADVERTISEMENT
